Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial.

Perner A, Haase N, Wetterslev J, Aneman A, Tenhunen J, Guttormsen AB, Klemenzson G, Pott F, Bødker KD, Bådstøløkken PM, Bendtsen A, Søe-Jensen P, Tousi H, Bestle M, Pawlowicz M, Winding R, Bülow HH, Kancir C, Steensen M, Nielsen J, Fogh B, Madsen KR, Larsen NH, Carlsson M, Wiis J, Petersen JA, Iversen S, Schøidt O, Leivdal S, Berezowicz P, Pettilä V, Ruokonen E, Klepstad P, Karlsson S, Kaukonen M, Rutanen J, Karason S, Kjældgaard AL, Holst LB, Wernerman J; Scandinavian Critical Care Trials Group.

Trials. 2011 Jan 27;12:24. doi: 10.1186/1745-6215-12-24.

2.

Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature.

Serpa Neto A, Veelo DP, Peireira VG, de Assunção MS, Manetta JA, Espósito DC, Schultz MJ.

J Crit Care. 2014 Feb;29(1):185.e1-7. doi: 10.1016/j.jcrc.2013.09.031. Epub 2013 Oct 22. Review.

PMID:
24262273
3.

Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.

Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J.

BMJ. 2013 Feb 15;346:f839. doi: 10.1136/bmj.f839. Review.

4.

Fluid replacement with hydroxyethyl starch in critical care--a reassessment.

Hartog CS, Welte T, Schlattmann P, Reinhart K.

Dtsch Arztebl Int. 2013 Jun;110(26):443-50. doi: 10.3238/arztebl.2013.0443. Epub 2013 Jun 28. Review.

5.

Fluid therapy in critical illness: a special focus on indication, the use of hydroxyethyl starch and its different raw materials.

Ertmer C, Kampmeier T, Van Aken H.

Curr Opin Anaesthesiol. 2013 Jun;26(3):253-60. doi: 10.1097/ACO.0b013e3283606b71. Review.

PMID:
23492982
6.

Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.

Mutter TC, Ruth CA, Dart AB.

Cochrane Database Syst Rev. 2013 Jul 23;(7):CD007594. doi: 10.1002/14651858.CD007594.pub3. Review.

PMID:
23881659
7.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I, Ker K.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000567. doi: 10.1002/14651858.CD000567.pub6. Review.

PMID:
23450531
8.

Scandinavian clinical practice guideline on choice of fluid in resuscitation of critically ill patients with acute circulatory failure.

Perner A, Junttila E, Haney M, Hreinsson K, Kvåle R, Vandvik PO, Møller MH; Scandinavian Society of Anaesthesiology and Intensive Care Medicine.

Acta Anaesthesiol Scand. 2015 Mar;59(3):274-85. doi: 10.1111/aas.12429. Epub 2014 Nov 2. Review.

PMID:
25363535
9.

CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients.

Hartog C, Reinhart K.

Intensive Care Med. 2009 Aug;35(8):1337-42. doi: 10.1007/s00134-009-1521-5. Epub 2009 Jun 17. Review.

PMID:
19533093
10.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000567. doi: 10.1002/14651858.CD000567.pub5. Review. Update in: Cochrane Database Syst Rev. 2013;(2):CD000567.

PMID:
22696320
11.

[Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].

Suttner S, Boldt J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Feb;39(2):71-7. Review. German.

PMID:
14767795
12.

To use or not to use hydroxyethyl starch in intraoperative care: are we ready to answer the 'Gretchen question'?

Heßler M, Arnemann PH, Ertmer C.

Curr Opin Anaesthesiol. 2015 Jun;28(3):370-7. doi: 10.1097/ACO.0000000000000194. Review.

PMID:
25887196
13.

Starch safety in resuscitation - when will we ever learn?

Parrish A, Blockman M.

S Afr Med J. 2013 Apr 29;103(6):365-7. doi: 10.7196/samj.6969. Review.

PMID:
23725952
14.

Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.

Patel A, Waheed U, Brett SJ.

Intensive Care Med. 2013 May;39(5):811-22. doi: 10.1007/s00134-013-2863-6. Epub 2013 Feb 22. Review.

15.

PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate.

Boldt J.

Intensive Care Med. 2009 Aug;35(8):1331-6. doi: 10.1007/s00134-009-1520-6. Epub 2009 Jun 17. Review.

PMID:
19533094
16.

Choice of Fluid Therapy in the Initial Management of Sepsis, Severe Sepsis, and Septic Shock.

Chang R, Holcomb JB.

Shock. 2016 Jul;46(1):17-26. doi: 10.1097/SHK.0000000000000577. Review.

17.

Colloid solutions for fluid resuscitation.

Bunn F, Trivedi D.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD001319. doi: 10.1002/14651858.CD001319.pub5. Review.

PMID:
22786474
18.

Plasma substitutes.

Boldt J, Suttner S.

Minerva Anestesiol. 2005 Dec;71(12):741-58. Review.

19.

Colloid solutions for fluid resuscitation.

Bunn F, Trivedi D.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD001319. doi: 10.1002/14651858.CD001319.pub4. Review. Update in: Cochrane Database Syst Rev. 2012;(7):CD001319.

PMID:
22696325
20.

Colloid solutions for fluid resuscitation in patients with sepsis: systematic review of randomized controlled trials.

Zhong JZ, Wei D, Pan HF, Chen YJ, Liang XA, Yang ZY, Tang HB.

J Emerg Med. 2013 Oct;45(4):485-95. doi: 10.1016/j.jemermed.2013.05.018. Epub 2013 Aug 7. Review.

PMID:
23932700

Supplemental Content

Support Center